ATTENTION ALL CUSTOMERS: Due to a recent change in our pharmacy software system, the process for submitting refill requests online has now changed. Our previous mobile app and your current login credentials will no longer work. Please click the My Pharmacy tab then Patient Portal to begin the new process. Thank you for your patience during this transition.
Antidepressants appear to increase people’s risk of sudden cardiac death, a new study says.
People taking the mood meds are more likely to die suddenly from heart problems, and their risk rises the longer they’re on the drugs, according to findings presented Monday in Vienna at a meeting of the European Society of Cardiology.
TUESDAY, Feb. 25, 2025 (HealthDay news) -- Antidepressants are frequently prescribed to people with dementia for symptoms like anxiety, depression, aggressiveness and sleeplessness.
But a specific class of antidepressant medications -- selective serotonin reuptake inhibitor...
"Black Box” warnings added to antidepressants might have contributed to an increase in suicide attempts and deaths among young people, a new evidence review claims.
The warnings say that antidepressants might be associated with suicidal thoughts and...
Psilocybin, the active ingredient in magic mushrooms, appears to ease depression symptoms at least as well as one of the most commonly used antidepressants, a new clinical trial shows.
Patients showed significant improvement in their depressive symptoms after taking either a single do...
Doctors sometimes turn to antidepressants as a means of easing older people's physical pain, but a new expert review finds there's little evidence to support the practice.
Antidepressants may even come with hazards for seniors who don't need them, said researchers from the University of Sydney in Australia.
"Harms of antidepressant use in older people are well documented," said stud...
A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research suggests.
Patients on the strongest dose of ketamine tablets saw significant improvement in their depression compa...
People coming off antidepressants often struggle with emotional and social turmoil, especially if they quit their meds cold turkey, a new study reports.
Challenges reported by patients quitting antidepressants included feeling overwhelmed by their emotions, finding social situations less enjoyable, and feeling detached and less empathetic towards others.
The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug's makers announced Thursday.
Sold under the name Zurzuvae, the medication can quickly ease severe postpartum depression and help women regain their emotional equilibrium following childbirth.
The medication, which is now stocked in specialty pharmacies, can also...
WEDNESDAY, Nov. 8, 2023 (Healthday News) -- A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients won't be able to afford the medication.
The party drug ketamine has gotten a lot of notice for its potential to help people with severe and persistent depression who haven't responded to other treatments.
But a new study has discovered the drug's effect may be in the heads of patients who take it.
Researchers from Stanford Medicine administered either ketamine or a placebo to 40 patients with depression who were already g...
An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS).
In the study, British researchers found that those taking amitriptyline were almost twice as likely as those taking a placebo to see an improvement in IBS symptoms.
Most folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.
Scientists have discovered this is because of physical changes in the brain that unfold over those first few weeks of using selective serotonin reuptake inhibitors (SSRIs) and lead to greater brain plasticity.
A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.
The study, led by Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University, found no symptom improvement in those taking the antidepressant at a dose of 100 milligrams (mg...
If you are a new mom struggling with postpartum depression, taking antidepressants known as selective serotonin reuptake inhibitors (SSRIs) may also bear benefits for your child's development.
That's according to new research that found the medications were associated with improvements in a child's behavior up to five years after birth.
You've been diagnosed with depression. What's next?
The cornerstone of treatment remains antidepressants, so it's likely your doctor will prescribe one for you, but which one might be best?
You will join millions around the world who struggle with how to treat the mental health disorder. An estimated 3.8% of the global population experiences depression, according to the
Many older adults with depression don't respond to their first antidepressant, so doctors will switch them to another one to see if that does the trick.
Now, new research suggests that the best strategy for these folks may instead be to add the antipsychotic drug Abilify (aripiprazole) to the original antidepressant.
"This is good news for older adults with difficult-to-treat ...
Antidepressants are often prescribed to people suffering from chronic pain, but a new evidence review argues that the science behind these prescriptions is shaky at best.
These drugs helped people in chronic pain in only a quarter of potential uses tested, and even then the effect ranged from low to moderate, according to a combined analysis of 26 prior reviews.
A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial smaller dose.
Study participants took 50 mg of the medication twice daily for 10 days, hoping to treat mild-to-moderate COVID-19 symptoms. A control group took a placebo.
TUESDAY, Sept. 6, 2022 (HealthDay Now) -- For Mary Christ, the idea that depression is a chemical imbalance in the brain has always felt true to her personal experience.
A former educator, Christ, 57, has taken antidepressants for much of her adult life. She experienced bouts of anxiety and panic attacks from...
There's good news for women with a mental health condition: Taking antidepressants early in pregnancy doesn't increase a baby's risk of having epilepsy or seizures, researchers say.
"The findings of this study are very important," said study co-author Ayesha Sujan of Indiana University Bloomington. "Pregnancy can be a trying time, and the addition of
Millions of Americans take antidepressants to combat low moods. But a large, new study suggests that these medications over time may do little to improve overall quality of life.
"We found the change in health-related quality of life to be comparable or similar between patients that used antidepressant medications and those who did not use them," said study lead author Omar Almohammed, an...
Older adults have a higher risk of delirium after hip and knee surgery if they're taking anxiety, depression or insomnia drugs, researchers say.
"Our findings show that different classes of medicine are riskier than others when it comes to causing delirium after surgery, and the older the patients are, the greater the risk," said lead study author Gizat Kassie. He is a postdoctoral resear...
Most prescriptions for the medication gabapentin are for unapproved uses -- and many patients end up taking it along with drugs that create potentially dangerous interactions.
That's the conclusion of a new study that looked at "off-label" use of gabapentin. In the United States, the drug is officially approved for treating certain seizures and some forms of nerve pain.
Certain commonly prescribed antidepressants appear to substantially lower the risk of dying among seriously ill COVID-19 patients, a large new study indicates.
Selective serotonin reuptake inhibitors (SSRIs) are among the most widely prescribed drugs for the treatment of depression. They include drugs like Lexapro (escitalopram), Paxil (paroxetine) and Zoloft (sertraline).
Illustrating the power of the mind to heal itself, new research suggests that the placebo effect could help drive antidepressants' effects against anxiety disorders.
The placebo effect refers to an increase in the success of a treatment when a patient expects a benefit.
A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients' risk of serious illness requiring hospitalization, according to a new study.
The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested positive for infection with SARS-CoV-2 and were deemed to be at high risk for a severe case of illness.
Fluvoxamine...
Ernie Mundell and Robert Preidt HealthDay Reporters
Antidepressants called selective serotonin reuptake inhibitors (SSRIs) are a mainstay of depression treatment, but a new study warns that taking common painkillers alongside SSRIs may raise the chances for intestinal bleeding.
In a review of 10 published studies involving 6,000 patients, researchers found that those taking SSRIs (such as Celexa, Paxil, Prozac and Zoloft) and pain medicati...
People who stop taking antidepressants after long-time use may face a high likelihood of spiraling into depression again, a new study suggests.
British researchers found that among patients who stopped taking their antidepressants because they felt well, 56% relapsed within a year. That compared with 39% of patients who stayed on medication.
